Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-08
DOI
10.1038/srep18848
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toward the development of effective transmission-blocking vaccines for malaria
- (2015) Daria Nikolaeva et al. Expert Review of Vaccines
- Transmission blocking malaria vaccines: Assays and candidates in clinical development
- (2015) R.W. Sauerwein et al. VACCINE
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
- (2014) PLOS MEDICINE
- Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets
- (2013) Simone C de Cassan et al. Expert Review of Vaccines
- Malaria vaccine technology roadmap
- (2013) Vasee S Moorthy et al. LANCET
- Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays
- (2013) Kazutoyo Miura et al. PLoS One
- A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice
- (2013) R. Mark Jones et al. PLoS One
- Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
- (2013) Richard L. Shimp et al. VACCINE
- Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques
- (2013) Yannick Vanloubbeeck et al. VACCINE
- Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
- (2013) Teresa Lambe et al. Scientific Reports
- A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis
- (2012) Alain C. Tissot et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Arranged Sevenfold: Structural Insights into the C-Terminal Oligomerization Domain of Human C4b-Binding Protein
- (2012) Thomas Hofmeyer et al. JOURNAL OF MOLECULAR BIOLOGY
- Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates
- (2012) Alexandra J. Spencer et al. PLoS One
- T Cell Responses Induced by Adenoviral Vectored Vaccines Can Be Adjuvanted by Fusion of Antigen to the Oligomerization Domain of C4b-Binding Protein
- (2012) Emily K. Forbes et al. PLoS One
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
- (2012) J. J. Moon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Requirement for Potent Adjuvants To Enhance the Immunogenicity and Protective Efficacy of Protein Vaccines Can Be Overcome by Prior Immunization with a Recombinant Adenovirus
- (2011) S. C. de Cassan et al. JOURNAL OF IMMUNOLOGY
- A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity
- (2011) Anna L. Goodman et al. PLoS One
- The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
- (2011) Alexander D. Douglas et al. Nature Communications
- Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines
- (2010) S. J. Draper et al. JOURNAL OF IMMUNOLOGY
- Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1
- (2010) Alexander D. Douglas et al. VACCINE
- Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T-Cell Responses
- (2009) A. Reyes-Sandoval et al. INFECTION AND IMMUNITY
- The Oligomerization Domain of C4-Binding Protein (C4bp) Acts as an Adjuvant, and the Fusion Protein Comprised of the 19-Kilodalton Merozoite Surface Protein 1 Fused with the Murine C4bp Domain Protects Mice against Malaria
- (2008) S. A. Ogun et al. INFECTION AND IMMUNITY
- Single-Dose Protection against Plasmodium berghei by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A
- (2008) S. Sridhar et al. JOURNAL OF VIROLOGY
- Effective induction of high-titer antibodies by viral vector vaccines
- (2008) Simon J Draper et al. NATURE MEDICINE
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now